USP 800 was a necessary step to maximize safety, but it also recommended many institutions reevaluate their facilities, equipment, processes, and staffing capacity, potentially costing millions of dollars.
It is imperative for health care professionals, especially pharmacists, to be well-informed regarding the physiological impact of Ramadan on diabetes.
Omidubicel is a stem cell-based product that utilizes nicotinamide to inhibit differentiation and to increase the migration, bone marrow homing, and engraftment efficiency of hematopoietic progenitor cells.
The pharmacy industry operates through people with different talents filling all types of responsibilities.
Affordability in drug pricing can be addressed by bringing the manufacturer and plan sponsor to negotiate costs and determine fair compensation for product and service providers in the supply chain.
No significant demographic or phenotypic differences were found between HLA-DQA1*05 carriers versus non-carriers, in either treatment group.
Providers who are sensitive to health literacy have contributed to positive quality improvement across various institutions.
Explore the definition of digiceuticals, current digiceutical products available, and pharmacy implications.
Language barriers between pharmacists and patients impacts medication adherence, patient education, and overall health outcomes, resulting in patient harm.
Poster presentations and speaking sessions at NASP showed the importance of clinical pharmacists in ambulatory care and opportunities to expand specialty pharmacy services in ambulatory care.
Pharmacists are well-positioned to address diabetes from a multifaceted approach.
It is imperative for health care professionals, especially pharmacists, to be well-informed regarding the physiological impact of Ramadan on diabetes.
Pharmacists and health care providers should be familiar with the management of xylazine overdose and withdrawal.
In 2019, an article in the Journal of the American College of Clinical Pharmacy encouraged pharmacists to engage professionally on social media, despite their having mostly avoided it for such purposes.
Seven new agents have received FDA approval since October 2022.
Since the first FDA biosimilar approval of filgrastim-sndz (Zarxio) in 2015, a total of 44 biosimilars for 15 originator products have been approved and more than 20 are marketed.
New agents can offer a more tailored approach to therapy selection.
Pharmacists' expertise is invaluable to prescribers who are unfamiliar with opioid use disorder treatment protocols.
PBM reforms and regulatory changes have reshaped the industry landscape.
Anna Sophie Mueller, MD discusses how imaging could advance risk identification in cardiovascular care.
Pharmacists are critically important in care delivery in their ability to influence patient success, patient-reported outcomes, and quality of life while reducing the burden on physicians and their clinical support teams.
Process helps prevent errors for individuals with chronic disorders who often have a higher risk of drug-drug interactions.
Conference Co-Chair and American Association for Cancer Research (AACR) Past President Elaine R. Mardis, PhD, explains that the conference provides pharmacy professionals with insights into the application of large-scale cancer genomics studies to real-world therapeutic responses.
The use of adulterated cannabinoids mixed with insecticides is becoming more common.
Targeted therapies have greatly improved patient outcomes over the past 20 years.
This review summarizes current utilization of anti-HER2 targeted therapy across several non-breast solid tumors in the setting of advanced disease.
The study findings signal the need for improved equality in PrEP prescribing across various institutions and settings.
The process of supporting a cause for our profession can be highly rewarding. As pharmacists, we must take charge to enact change.
Leaders Must Continue to Prioritize Empathy and Human Connection.